Künstliche Luft Zur Medizinischen Anwendung (Oxygen)

Oxygen delivered via inhalation raises the partial pressure of oxygen in the lungs, enhancing diffusion across the alveolar membrane into the bloodstream. This increases the amount of oxygen bound to hemoglobin, improving delivery to tissues and supporting cellular metabolism, especially during low‑oxygen conditions.

The prescribed dose of Künstliche Luft Zur Medizinischen Anwendung is determined by the treating clinician based on the patient’s oxygen saturation, underlying condition, and delivery system. Dosage is individualized and should follow the prescriber’s instructions and institutional protocols.

Oxygen therapy is generally considered safe when medically indicated during pregnancy or breastfeeding, as it does not cross the placenta in harmful amounts. However, the decision to use supplemental oxygen should be made by a qualified healthcare professional who evaluates the risks and benefits for mother and child.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Künstliche Luft Zur Medizinischen Anwendung is a medical‑grade oxygen gas supplied in cylinders, offering high purity and reliable flow rates. Compared with liquid oxygen systems, cylinders are portable and easier to store, while liquid oxygen provides larger volumes for high‑capacity facilities. Choice depends on facility needs, infrastructure, and usage frequency.

Store the oxygen cylinders at ambient temperature, upright, and secured to prevent tipping. Keep them away from heat sources, direct sunlight, and any ignition sources. Ensure regulators and connections are inspected regularly for leaks, and follow local regulations for medical gas storage.

Künstliche Luft Zur Medizinischen Anwendung is administered by inhalation using approved delivery devices such as flow meters, nasal cannulas, or face masks. The prescriber sets the flow rate and duration based on the patient’s oxygen saturation targets and clinical condition.

Serious risks include pulmonary oxygen toxicity, central nervous system toxicity leading to seizures, retinopathy of prematurity in neonates, and fire hazards due to increased flammability. Patients should be monitored closely for signs of toxicity, and oxygen should never be used near open flames.

Patients with known hypersensitivity to oxygen delivery equipment, those with uncontrolled fire‑hazard environments, or individuals for whom supplemental oxygen is contraindicated by their physician should not use Künstliche Luft Zur Medizinischen Anwendung. Clinical assessment is essential before initiating therapy.